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Urology in the Time of COVID19
Managing Urology Consultations
During COVID-19 Pandemic:
Application of a Structured Care
Pathway
Alex Borchert, Lee Baumgarten, Deepansh Dalela, Marcus Jamil, Jeffrey Budzyn,
Natalija Kovacevic, Grace Yaguchi, Isaac Palma-Zamora, Sara Perkins, Mahdi Bazzi,
Phil Wong, Akshay Sood, James Peabody, Craig G. Rogers, Ali Dabaja, and
Humphrey Atiemo
OBJECTIVE To describe and evaluate a risk-stratified triage pathway for inpatient urology consultations during
the SARS-CoV-2 (COVID-19) pandemic. This pathway seeks to outline a urology patient care
strategy that reduces the transmission risk to both healthcare providers and patients, reduces the
healthcare burden, and maintains appropriate patient care.
MATERIALS AND
METHODS
Consultations to the urology service during a 3-week period (March 16 to April 2, 2020) were tri-
aged and managed via one of 3 pathways: Standard, Telemedicine, or High-Risk. Standard con-
sults were in-person consults with non COVID-19 patients, High-Risk consults were in-person
consults with COVID-19 positive/suspected patients, and Telemedicine consults were telephonic
consults for low-acuity urologic issues in either group of patients. Patient demographics, consulta-
tion parameters and consultation outcomes were compared to consultations from the month of
March 2019. Categorical variables were compared using Chi-square test and continuous variables
using Mann-Whitney U test. A P value <.05 was considered significant.
RESULTS Between March 16 and April 2, 2020, 53 inpatient consultations were performed. By following
our triage pathway, a total of 19/53 consultations (35.8%) were performed via Telemedicine with
no in-person exposure, 10/53 consultations (18.9%) were High-Risk, in which we strictly con-
trolled the urology team member in-person contact, and the remainder, 24/53 consultations
(45.2%), were performed as Standard in-person encounters. COVID-19 associated consultations
represented 18/53 (34.0%) of all consultations during this period, and of these, 8/18 (44.4%) were
managed successfully via Telemedicine alone. No team member developed COVID-19 infection.
CONCLUSION During the COVID-19 pandemic, most urology consultations can be managed in a patient and
physician safety-conscious manner, by implementing a novel triage pathway. UROLOGY 141: 7
−11, 2020. © 2020 Elsevier Inc.
As of April 9, 2020, the World Health Organiza-tion reported nearly 400,000 cases of and 12,740deaths attributed to COVID-19 in the United
States (US) alone.1 In the state of Michigan, over 80% of
cases and deaths are occurring in metropolitan Detroit,
making it the third largest epicenter per population in the
US,2,3 causing unprecedented changes to the healthcare
environment. In the context of rapidly evolving guidelines
for personal protective equipment and diagnostic testing
for healthcare workers,4 as well as the internal reassignment
of clinical team members to other patient care teams,
implementation of new departmental protocols were
needed. The present report details the efforts of the Urol-
ogy Department (Henry Ford Hospital, Detroit, MI) to
develop and implement an inpatient consultation triage
pathway to minimize unnecessary exposure for providers
and patients, while providing safe and effective care during
the COVID-19 pandemic.
MATERIALS AND METHODS
This study was conducted as a part of necessary transition of
care delivery at a tertiary care institution. As the COVID-19
pandemic spread in the state of Michigan, there was a rapid
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increase in COVID-19 positive patients within the health
system, with an accordant increase in COVID-19 suspected
and positive inpatient and emergency department consulta-
tions. Thus, on March 16, 2020, the decision was made to
implement a new Urology Consultation Triage Pathway
(Fig. 1).
Briefly, all consultations for the Urology service were
assessed based on clinical context (complexity and time-sen-
sitivity of urological issue/s), resources available with the
consulting teams to address minor urological issues, and the
COVID-19 status of the patient (confirmed, suspected, not
suspected) at time of consultation. Patients were then triaged
into one of 3 pathways:
(1)Telemedicine: Patients with nonurgent/nonemergent
inpatient issues were managed with telemedicine consul-
tation composed of chart review and discussion with pri-
mary team providers, with or without patient telephone
interview (depending upon patient’s clinical status).
These patients could be COVID-19 positive, suspected or
negative.
(2) Standard: Patients with urgent/emergent inpatient needs but
not proven/suspected COVID-19 positive had standard Urol-
ogy consultation (though still minimizing the number of
urology residents and/or attendings involved in direct patient
care).
(3)High-risk: Patients with urgent/emergent inpatient needs
who were suspected/proven COVID-19 positive were
deemed High-risk urology consultations (seen by only 1 urol-
ogy resident and/or attending, especially if a bedside proce-
dure or operative intervention was necessary). Personal
protective equipment were donned, including N95 masks,
per CDC and hospital policy.
A prospective database was maintained for this period,
tracking the management of patients in each of the 3 triage
pathways. Data were collected for a 3-week period (from
March 16, 2020 to April 2, 2020), and analyzed between
April 4 and April 7, 2020. Data points included age, sex, race,
pertinent medical/surgical history, primary hospital diagnosis
and consulting service. Management and treatment variables
included reason for consultation, type of consultation per-
formed, intervention performed, and COVID-19 status (at
time of consultation and final). Interventions were defined as
nonprocedural recommendations (medication and/or planned
follow-up), operative procedure, bedside procedures (catheter
placement or change, cystoscopy, incision and drainage, penile
injections/aspiration/irrigation, etc.), or Interventional Radiology
(IR) procedures.
In order to compare consultation workflow in the period pre-
ceding the implementation of the pathway, similar data points
were extracted for all urology consultations for the month of
March 2019 (March 1, 2019 to March 31, 2019). This latter
cohort served as a control group, with no ongoing regional or
national health care stressors.
Categorical variables were compared using Chi-square test
(with Yates correction for n<5) or Fisher’s exact test as appropri-
ate, and continuous variables using Mann-Whitney U test. A
P value <.05 was considered significant. Statistical analyses were
done using MS Excel version 15 (Microsoft, Redmond, WA)
and IBM SPSS version 21 (IBM, Armonk, NY). The study was
approved by the International Review Board committee and
Figure 1. New algorithm for triaging inpatient urology consultations during COVID-19 pandemic.“Color version available
online.”
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exempted from informed consent under local institutional
protocols.
RESULTS
Table 1 shows the demographics and consultation characteris-
tics of urology consultations during the specified time periods.
A total of 154 consultations were analyzed, 101 consultations
from March 2019 and 53 from March 2020. The median age,
sex, race and consulting service were similar between the
groups. The most common reasons for consultation were hema-
turia, urinary retention and kidney stones and this was not sig-
nificantly different between the 2019 and 2020 groups (P = .2).
A greater proportion of patients were managed nonprocedur-
ally in March 2020 compared to March 2019 (66% vs 51.5%),
with fewer patients undergoing operative intervention (9.4%
vs 21.7%) and more undergoing IR interventions (9.4% vs
0.9%) (P = .03). In March 2019, only Standard consultations
were performed. In March 2020, following implementation of
our triage pathway, a total of 19/53 consultations (35.8%) were
performed via Telemedicine with no in-person exposure, 10/53
consultations (18.9%) were High-risk, and the remainder, 24/
53 consultations (45.2%), were performed as Standard in-per-
son encounters.
Table 2 shows consultation characteristics for March 2020.
Consultations managed by Telemedicine were most com-
monly for urinary retention 6/16 (31.6%), kidney stones 4/19
(21.1%) and hematuria 3/19 (15.8%), compared to the High-
risk consultations, where the vast majority were for urinary
retention 7/10 (70%). Of the Telemedicine consultations,
nearly 85% (16/19) were managed nonprocedurally (neither
an intervention from urology or IR was required).
None of the residents or faculty caring for urology consulta-
tion patients during the March 2020 period developed symptoms
suggestive of COVID-19 and/or tested positive for it.
Figure 2 depicts the number of COVID positive patients
admitted to our hospital over the study period, as well as, the
number of Standard, Telemedicine, and High-risk consulta-
tions performed on each day after the triage pathway was
implemented.
Table 1. Demographics and consultation parameters for inpatient consultations from March 1-31, 2019 and March 16-April
2, 2020
March 2019 March 2020 P Value
Total patients 101 53
Consults/day (Median, IQR) 3.2 (1.5-4) 2.8 (1-4) .6
Age (Median, IQR) years 63 (43-73) 59 (44-72) .8
Sex, n (%) .7
Male 68 (67.3) 37 (69.8)
Female 33 (23.7) 16 (30.2)
Race, n (%) .2
African American 42 (37.1) 27 (50.9)
Caucasian 40 (35.4) 11 (20.8)
Hispanic 3 (2.6) 1 (1.9)
Unrecorded 16 (14.2) 14 (26.4)
Primary hospital diagnosis, n (%) .02
Pulmonary 5 (4.9) 10 (19.2)
Cardiac 5 (4.9) 0 (0)
Genitourinary 72 (71.3) 27 (51.9)
Other 19 (18.8) 15 (28.8)
Consulting service, n (%) .4
Emergency department 57 (56.4) 27 (50.9)
Medicine 33 (32.7) 15 (28.3)
Surgery 1 (0.9) 4 (7.5)
Intensive care unit 10 (9.9) 7 (13.2)
Reason for consult, n (%) .2
Hematuria 21 (20.8) 11 (20.8)
Urinary retention 11 (10.9) 15 (28.3)
Abscess/GU infection 12 (11.9) 4 (7.5)
Kidney stone 17 (16.8) 9 (17.0)
Hydronephrosis 14 (13.9) 4 (7.5)
Nephrostomy tube malfunction 1 (0.9) 2 (3.8)
Scrotal pain 3 (2.9) 3 (5.6)
Other 22 (21.7) 5 (9.4)
Consult type, n (%) <.01
Standard 101 (100) 24 (45.2)
Telemedicine - 19 (35.8)
High-risk - 10 (18.9)
Intervention, n (%) .03
Nonprocedural recommendations 52 (51.5) 35 (66.0)
Operating room 22 (21.7) 5 (9.4)
Bedside procedure/catheter
placement
26 (25.7) 8 (15.1)
Interventional radiology 1 (0.9) 5 (9.4)
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COMMENT
In response to the COVID-19 pandemic, all aspects of
medical and surgical patient care have been trans-
formed. Because a significant proportion of COVID-19
infections are caused by undocumented exposure,5
decreasing in-person contact with emergency depart-
ment and hospitalized patients is of utmost importance.
The described consultation triage pathway allows for
necessary urgent and emergent urologic care, while
minimizing exposure that would be associated with
standard urology consultations.
During the March 2020 study period, we managed over
half of all consultations (54.7%) using a modified consul-
tation type (Telemedicine or High-risk), and for some
days, the majority of consultations were managed using
Telemedicine alone.
Importantly, demographics and consultation character-
istics, with the exception of primary hospital diagnosis,
were not significantly different in March 2019 and March
2020, suggesting that March 2020 (other than the pres-
ence of the COVID-19 pandemic), represented a typical
month of urologic consultations. More consults during
Table 2. Consult parameters and COVID-19 status, by consult type for March 16-April 2, 2020
Standard (n = 24) Telemedicine (n = 19) High-Risk (n = 10)
Reason for consultation, n (%)
Hematuria 7 (29.2) 3 (15.8) 1 (10)
Urinary retention 2 (8.3) 6 (31.6) 7 (70)
Abscess/GU infection 3 (12.5) 1 (5.2) 0
Kidney stone 4 (16.7) 4 (21.1) 1 (10)
Hydronephrosis 2 (8.3) 1 (5.2) 1 (10)
Nephrostomy tube malfunction 0 2 (10.5) 0
Scrotal pain 3 (12.5) 0 0
Other 3 (12.5) 2 (10.5) 0
Intervention performed, n (%)
Nonprocedural recommendations 15 (62.5) 16 (84.2) 4 (40)
Operating room 5 (20.9) 0 0
Bedside procedure/catheter placement 3 (12.5) 0 5 (50)
Interventional radiology 1 3 (15.8) 1 (10)
COVID-19 status at time of consultation, n (%)
Positive 0 2 (10.5) 4 (40)
Pending 0 6 (31.6) 6 (60)
Not tested 24 (100) 11 (57.9) 0
COVID-19 final status, n (%)
Positive - 4 (21.1) 4 (40)
Negative - 4 (21.1) 6 (60)
Not tested 24 (100) 11 (57.9) 0
Figure 2. Consultation type, and COVID-19 cases, by day, from March 16-April 2, 2020. “Color version available online."
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2020 had a primary pulmonary diagnosis, likely reflecting
the presence of the COVID-19 pandemic.
Notably, fewer consults in March 2020, 5/53 (9.4%),
resulted in operative intervention compared to 22/101
(21.7%) consults in March 2019. This can, in part, be
attributed to the Henry Ford Health System policy
enacted on March 15 2020, which postponed all nontime
sensitive surgeries. Unsurprisingly, more patients were
managed with nonprocedural recommendations and IR
procedures in March 2020, which likely reflects both
departmental and hospital-wide efforts to preserve operating
room space and all associated resources.
Of note, while 34.0% of consultations in the 2020 study
period were for COVID-19 status positive or COVID-19
status pending patients, our hospital has quickly become a
majority COVID-19 facility, and we expect the majority
of urology consultations moving forward during this pan-
demic to be classified as either Telemedicine or High-risk,
and managed accordingly.
Contemporaneously, and in conjunction with develop-
ment of this pathway, we restructured our urology service
into 2 teams to optimize patient care and minimize unnec-
essary exposures, described similarly at other institutions.6
Each week, “Team A” covers urologic care across our cov-
ered hospitals, including additional satellite facilities,
while “Team B” covers COVID-19 and non-COVID-19
units as needed. These teams switch responsibilities each
week. This system has allowed us to help in other hospital
departments and units, while ensuring adequate coverage
for any needed urologic care.
Limitations of the study include the following. There
are a relatively small number of consultations tracked
over a short period of time. The control group, while it
appeared well-matched in our analysis, may represent a
different cohort of consultations than our study group.
The pathway we utilized is nonvalidated. Lastly, we have
no follow-up to identify outcomes associated with the
consultations performed during the study.
The authors recognize that by using this pathway, there
may be a suggestion of decreased value associated with some
urology consultations. In addition to urologic procedures
and recommendations, urologists provide reassurance about
and explanations for urologic problems, while facilitating
and encouraging outpatient follow-up.7,8 Additionally, the
reimbursement pattern for Telemedicine consultations was
evolving during the study period. As of March 30, 2020, the
Accreditation Council for Graduate Medical Education Pro-
gram requirements VI.A.2.(1).(b) and revised Centers for
Medicare and Medicaid rules now permit faculty members
to provide direct supervision through telecommunications
technology. These changes allow residents to perform
Telehealth consultations, while being staffed remotely,
as billable encounters.9-11
By utilizing Telemedicine during consultation with
patients with nonurgent urologic problems, we have been
able to provide appropriate care and counseling, while
mitigating the surge of future outpatient urologic visits
and care following the COVID-19 crisis.9
CONCLUSION
Implementing a urology consultation triage pathway
allowed for appropriate inpatient urologic consultation
management while minimizing the risk of exposure for
both patients and urology team members during the
COVID-19 pandemic. Given the fluidity of the current
circumstances, we acknowledge the need to continue to
adapt to any new and unforeseen circumstances, but we
hope that this pathway may provide a useful framework
for other urology departments.
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